اسم المنتج |
Propikacin |
الاسم المستعار |
Propikacin [USAN:INN]; UK 31,214; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1-6)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl(1-4))-2-deoxy-N(sup 1)-(2-hydroxy-1-(hydroxymethyl)ethyl)-; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl(1-4)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl(1-6))-2-deoxy-N(sup 3)-(2-hydroxy-1-(hydroxymethyl)ethyl)-L-streptamine; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl(1->4)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl(1->6))-2-deoxy-N(sup 3)-(2-hydroxy-1-(hydroxymethyl)ethyl)-L-streptamine; Propikacina; Propikacina [INN-Spanish]; Propikacine; Propikacine [INN-French]; Propikacinum; Propikacinum [INN-Latin]; UNII-9X6F5H479X; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1->6)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl(1->4))-2-deoxy-N(sup 1)-(2-hydroxy-1-(hydroxymethyl)ethyl)-; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxy-N1-(2-hydroxy-1-(hydroxymethyl)ethyl)-; 6-amino-3-[(3-amino-3-deoxyhexopyranosyl)oxy]-4-[(1,3-dihydroxypropan-2-yl)amino]-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxyhexopyranoside; (1R,2S,3S,4R,6S)-6-amino-3-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxy-4-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}cyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside |
الصيغة الجزيئية |
C21H43N5O12 |
الوزن الجزيئي الغرامي |
557.5924 |
InChI |
InChI=1/C21H43N5O12/c22-2-9-14(31)15(32)12(25)20(35-9)37-18-7(23)1-8(26-6(3-27)4-28)19(17(18)34)38-21-16(33)11(24)13(30)10(5-29)36-21/h6-21,26-34H,1-5,22-25H2/t7-,8+,9+,10+,11-,12+,13+,14+,15+,16+,17-,18+,19-,20+,21+/m0/s1 |
إستراتيجية المساعدة القطرية |
66887-96-5 |
بنية جزيئية |
|
كثافة |
1.588g/cm3 |
نقطة الغليان |
910.965°C at 760 mmHg |
معامل الإنكسار |
1.664 |
نقطة الوميض |
504.733°C |
علامات على البضائع الخطرة |
|
خطر المصطلحات |
|
شروط الأمن |
|
|